|
|
Genionics is a privately owned company dedicated to ion channel research and offers a range of products
to provide assistance in drug discovery, diagnostics and clinical management. The company uses its
proprietary ChanClone™ technology to provide next generation ion channel cell lines ready-to-use
in drug screening projects.
This technology opportunity enables the design of ion channel cell lines in ultra-fast mode. We are in the process of building up a comprehensive ion channel cell collection including polymorphic and mutated ion channel variants.
Bridging the gap between genetic diversity and in vitro screening of ion channels is our vision. We promote ion channel allele screening in order to accelerate the advancement of personalized medicine in the areas of ion channel diseases. Genionics is located at the Biotech Center of Zurich in Switzerland.
|
|
|
13-14 November 2008
Channelopathy Database
Together with the Channelopathy Foundation Genionics organized a roundtable
meeting with opinion leaders to initiate the Channelopathy Database Project, Zurich,
Switzerland.
28 October 2008
Launch of Channelopathy Foundation
As initiator of project, Genionics AG successfully established
the Channelopathy Foundation, Lucerne, Switzerland.
7-9 October 2008
Biotechnica Hannover
Genionics was at the Biotechnica to introduce its new
ion channel cell lines in Hannover, Germany.
30 September – 2 October 2008
CPhI Worldwide
Our ChanCloneTM ion channel cell lines have been presented
at the CPhI Worldwide Frankfurt, Germany.
|
|
|
 |
Ion Channel collection
Behind all our ion channel cell products stands extensive know-how. We put in extra efforts to provide you with high-end ion channel reagents. A broad collection of ion channels is available here to let you profit from our experience. |
|